Nile Therapeutics Inc. lost $6 million in 2010. In 2009, the San Mateo business lost $7.9 million.
The company (NASDAQ: NLTX) reported no revenue for either year. It did bring in some interest income in both years.
At the end of 2010, Nile had accumulated a deficit of $39.9 million.